76
|
Adare A, Aidala C, Ajitanand NN, Akiba Y, Al-Bataineh H, Alexander J, Alfred M, Angerami A, Aoki K, Apadula N, Aramaki Y, Asano H, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Bandara NS, Bannier B, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Beaumier M, Beckman S, Belikov S, Belmont R, Bennett R, Berdnikov A, Berdnikov Y, Bhom JH, Blau DS, Bok JS, Boyle K, Brooks ML, Bryslawskyj J, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Campbell S, Caringi A, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Conesa Del Valle Z, Connors M, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Danley TW, Das K, Datta A, Daugherity MS, David G, Dayananda MK, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Diss PB, Do JH, Donadelli M, D'Orazio L, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Feege N, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gal C, Gallus P, Garg P, Garishvili I, Ge H, Giordano F, Glenn A, Gong H, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gunji T, Gustafsson HÅ, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Hamilton HF, Han R, Han SY, Hanks J, Hasegawa S, Haseler TOS, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hornback D, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ichimiya R, Ikeda Y, Imai K, Inaba M, Iordanova A, Isenhower D, Ishihara M, Issah M, Ivanishchev D, Iwanaga Y, Jacak BV, Jezghani M, Jia J, Jiang X, Jin J, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kamin J, Kanda S, Kang JH, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Key JA, Khachatryan V, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim C, Kim DJ, Kim EJ, Kim GW, Kim M, Kim YJ, Kimelman B, Kinney E, Kiss Á, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kochenda L, Komkov B, Konno M, Koster J, Kotov D, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee S, Lee SH, Leitch MJ, Leite MAL, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Makek M, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Miki K, Milov A, Mishra DK, Mitchell JT, Miyasaka S, Mizuno S, Mohanty AK, Montuenga P, Moon HJ, Moon T, Morino Y, Morreale A, Morrison DP, Moukhanova TV, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Nattrass C, Netrakanti PK, Newby J, Nguyen M, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Orjuela Koop JD, Osborn JD, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park IH, Park JS, Park S, Park SK, Park WJ, Pate SF, Patel M, Pei H, Peng JC, Pereira H, Perepelitsa DV, Perera GDN, Peressounko DY, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ramson BJ, Ravinovich I, Read KF, Rembeczki S, Reygers K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Rowan Z, Rubin JG, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Sako H, Samsonov V, Sano S, Sarsour M, Sato S, Sato T, Sawada S, Schaefer B, Schmoll BK, Sedgwick K, Seele J, Seidl R, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Snowball M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stenlund E, Stepanov M, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takagui EM, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Themann H, Thomas D, Thomas TL, Tieulent R, Timilsina A, Todoroki T, Togawa M, Toia A, Tomášek L, Tomášek M, Torii H, Towell CL, Towell R, Towell RS, Tserruya I, Tsuchimoto Y, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White AS, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, Yoo JH, Yoon I, You Z, Young GR, Younus I, Yu H, Yushmanov IE, Zajc WA, Zelenski A, Zhou S, Zou L. Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at √[s(NN)]=200 GeV. PHYSICAL REVIEW LETTERS 2016; 116:122301. [PMID: 27058071 DOI: 10.1103/physrevlett.116.122301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2015] [Indexed: 06/05/2023]
Abstract
Jet production rates are measured in p+p and d+Au collisions at sqrt[s_{NN}]=200 GeV recorded in 2008 with the PHENIX detector at the Relativistic Heavy Ion Collider. Jets are reconstructed using the R=0.3 anti-k_{t} algorithm from energy deposits in the electromagnetic calorimeter and charged tracks in multiwire proportional chambers, and the jet transverse momentum (p_{T}) spectra are corrected for the detector response. Spectra are reported for jets with 12<p_{T}<50 GeV/c, within a pseudorapidity acceptance of |η|<0.3. The nuclear-modification factor (R_{dAu}) values for 0%-100% d+Au events are found to be consistent with unity, constraining the role of initial state effects on jet production. However, the centrality-selected R_{dAu} values and central-to-peripheral ratios (R_{CP}) show large, p_{T}-dependent deviations from unity, challenging the conventional models that relate hard-process rates and soft-particle production in collisions involving nuclei.
Collapse
|
77
|
Banning EB, Hawkins AL, Stewart ST, Hitchings P, Edwards S. Quality Assurance in Archaeological Survey. JOURNAL OF ARCHAEOLOGICAL METHOD AND THEORY 2016; 24:466-488. [PMID: 29266125 PMCID: PMC5732596 DOI: 10.1007/s10816-016-9274-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
To have confidence in the results of an archaeological survey, whether for heritage management or research objectives, we must have some assurance that the survey was carried out to a reasonably high standard. This paper discusses the use of Quality Assurance (QA) approaches and empirical methods for estimating surveys' effectiveness at discovering archaeological artifacts as a means for ensuring quality standards. We illustrate with the example of two surveys in Cyprus and Jordan in which resurvey, measurement of surveyor "sweep widths," and realistic estimates of survey coverage allow us to evaluate explicitly the probability that the survey missed pottery or lithics, as well as to decide when survey has been thorough enough to warrant moving to another survey unit.
Collapse
|
78
|
Dafoe S, Chapman MJ, Edwards S, Stiller K. Overcoming barriers to the mobilisation of patients in an intensive care unit. Anaesth Intensive Care 2016; 43:719-27. [PMID: 26603796 DOI: 10.1177/0310057x1504300609] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
We conducted a quality improvement project aimed at increasing the frequency of mobilisation in our ICU. We designed a four-part quality improvement project comprising: an audit documenting the baseline frequency of mobilisation; a staff survey evaluating perceptions of the barriers to mobilisation; identification of barriers that were amenable to change and implementation of strategies to address these; and a follow-up audit to determine their effectiveness. The setting was a tertiary care, urban, public hospital ICU in South Australia. All patients admitted to the ICU during the two audit periods were included in the audits, while all permanent/semi-permanent ICU staff were eligible for inclusion in the staff survey. We found that patient- and institution-related factors had the greatest impact on the mobilisation of patients in our ICU. Barriers identified as being amenable to change included insufficient staff education about the benefits of mobilisation, poor interdisciplinary communication and lack of leadership regarding mobilisation. Various strategies were implemented to address these barriers over a three-month period. Multivariable analyses showed that three out of four mobility outcomes did not significantly change between the baseline and follow-up audits, with a significant difference in favour of the baseline audit found for the fourth mobility outcome (maximum level of mobility). We concluded that implementing relatively simple measures to improve staff education, interdisciplinary communication and leadership regarding early progressive mobilisation was ineffective at improving mobility outcomes for patients in a large tertiary-level Australian ICU. Other strategies, such as changing sedation practices and/or increasing staffing, may be required to improve mobility outcomes of these patients.
Collapse
|
79
|
Bodnarchuk MS, Heyes DM, Dini D, Chahine S, Edwards S. Role of Deprotonation Free Energies in pKa Prediction and Molecule Ranking. J Chem Theory Comput 2015; 10:2537-45. [PMID: 26580774 DOI: 10.1021/ct400914w] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A computationally efficient classical molecular simulation technique is derived for ranking the pKa values of a set of chemically similar congeneric molecules in an implicit solvent model of water. This uses the deprotonation free energy of the titratable group in the gas and aqueous phases obtained by thermodynamic integration (TI). For a series of alcohols and acids a strong linear correlation is demonstrated between the experimental pKa and the deprotonation free energy difference in the gas and liquid phases. These calculations also show that classical TI is more efficient than slow-growth TI in calculating deprotonation free energies for the series of molecules considered herein.
Collapse
|
80
|
Hampson G, Edwards S, Sankaralingam A, Harrington DJ, Voong K, Fogelman I, Frost ML. Circulating concentrations of vitamin E isomers: Association with bone turnover and arterial stiffness in post-menopausal women. Bone 2015; 81:407-412. [PMID: 26271527 DOI: 10.1016/j.bone.2015.08.010] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/13/2015] [Revised: 08/06/2015] [Accepted: 08/08/2015] [Indexed: 10/23/2022]
Abstract
The effects of vitamin E on cardiovascular and bone health are conflicting with beneficial and detrimental findings reported. To investigate this further, we carried out a cross-sectional study to determine the relationship between circulating concentrations of the 2 vitamin E isomers, α- and γ-tocopherol (TP) with bone turnover and arterial stiffness. Two hundred and seventy eight post-menopausal women with mean age [SD] 60.9 [6.0] years were studied. Fasting serum α-TP and γ-TP, bone turnover markers; procollagen type 1 amino-terminal propeptide (P1NP) and C-terminal telopeptide of type 1 collagen (CTX), parathyroid hormone (PTH), total cholesterol (TC) and triglycerides (TG) were measured. Pulse wave velocity (PWV) and central augmentation index (AI) as markers of arterial stiffness were also determined. A positive correlation was observed between α-TP and γ-TP (r=0.14, p=0.022). A significant negative association between α-TP and P1NP only was seen in multiple linear regression analysis following adjustment for serum TC and TG (p=0.016). In a full multi-linear regression model, following correction for age, years since menopause, smoking habits, alcohol intake, use of calcium supplements, BMI, PTH, serum calcium, and estimated glomerular filtration rate (eGFR), the association between α-TP and P1NP remained significant (p=0.011). We did not observe any significant association between γ-TP or α-TP/γ-TP ratio with P1NP or CTX. P1NP was significantly lower in subjects with α-TP concentrations of >30 μmol/L (α-TP >30 μmol/L; P1NP: 57.5 [20.7], α-TP<30 μmol/L; P1NP: 65.7 [24.9] μg/L, p=0.005). PWV was significantly associated with α-TP/γ-TP ratio (p=0.04) but not with serum α-TP or γ-TP in a full multi-linear regression model adjusting for serum lipids, age, and blood pressure. The data suggest that high serum concentrations of α-TP may have a negative effect on bone formation. The balance of α-TP and γ-TP may be important in maintaining arterial compliance. Longitudinal studies are needed to investigate the impact of the vitamin E isomers on bone and cardiovascular health.
Collapse
|
81
|
Sundararajan K, Milne D, Edwards S, Chapman MJ, Shakib S. Anti-seizure prophylaxis in critically ill patients with traumatic brain injury in an intensive care unit. Anaesth Intensive Care 2015; 43:646-51. [PMID: 26310417 DOI: 10.1177/0310057x1504300515] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The objectives of this prospective observational study were to determine the proportion of patients with traumatic brain injury who received effective anti-seizure prophylaxis. The study was conducted in a tertiary level ICU of a major trauma referral centre between February 2012 and August 2013. A total of 2361 patients were admitted to the ICU in this study period, of whom125 patients (index) with traumatic head injury were included in this study. The patients had a mean age of 45 years (SD=19), a mean score on the Glasgow Coma Scale of 9 (SD=4), a mean injury severity score of 27 (SD=13) and a mean APACHE III score of 55 (SD=27). Only 13.6 % (17 of 125) of patients were given anti-seizure prophylaxis and phenytoin levels were measured in 9.6% (12 of 125). Although all 12 patients achieved an effective concentration for phenytoin therapy (>40 µmol/l) after the loading dose, no patient had their target concentration consistently maintained in the recommended therapeutic range (40 to 80 µmol/l) throughout the seven-day monitoring period. There was wide fluctuation in phenytoin levels in the patients in this study. Twenty-two (18%) of the index patients had post-traumatic seizures, indicating a high prevalence for this study. Poor compliance with guidelines could possibly explain this phenomenon. Future studies are needed to look at the dosing and monitoring of phenytoin and/or alternative anti-seizure prophylaxis in patients with traumatic brain injury.
Collapse
|
82
|
Adare A, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Bataineh H, Alexander J, Alfred M, Al-Ta'ani H, Andrews KR, Angerami A, Aoki K, Apadula N, Aphecetche L, Appelt E, Aramaki Y, Armendariz R, Aronson SH, Asai J, Asano H, Aschenauer EC, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Baldisseri A, Bandara NS, Bannier B, Barish KN, Barnes PD, Bassalleck B, Basye AT, Bathe S, Batsouli S, Baublis V, Baumann C, Bazilevsky A, Beaumier M, Beckman S, Belikov S, Belmont R, Ben-Benjamin J, Bennett R, Berdnikov A, Berdnikov Y, Bhom JH, Bickley AA, Blau DS, Boissevain JG, Bok JS, Borel H, Boyle K, Brooks ML, Broxmeyer D, Bryslawskyj J, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Camacho CM, Campbell S, Caringi A, Castera P, Chang BS, Chang WC, Charvet JL, Chen CH, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Churyn A, Chvala O, Cianciolo V, Citron Z, Cleven CR, Cole BA, Comets MP, Conesa del Valle Z, Connors M, Constantin P, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Danley D, Das K, Datta A, Daugherity MS, David G, Dayananda MK, Deaton MB, DeBlasio K, Dehmelt K, Delagrange H, Denisov A, d'Enterria D, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Diss PB, Do JH, Donadelli M, D'Orazio L, Drapier O, Drees A, Drees KA, Dubey AK, Durham JM, Durum A, Dutta D, Dzhordzhadze V, Edwards S, Efremenko YV, Egdemir J, Ellinghaus F, Emam WS, Engelmore T, Enokizono A, En'yo H, Esumi S, Eyser KO, Fadem B, Feege N, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gadrat S, Gal C, Gallus P, Garg P, Garishvili I, Ge H, Giordano F, Glenn A, Gong H, Gong X, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gu Y, Gunji T, Guo L, Gustafsson HÅ, Hachiya T, Hadj Henni A, Haegemann C, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Hamilton HF, Han R, Han SY, Hanks J, Harada H, Harper C, Hartouni EP, Haruna K, Hasegawa S, Haseler TOS, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hiejima H, Hill JC, Hobbs R, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hori Y, Hornback D, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Imrek J, Inaba M, Inoue Y, Iordanova A, Isenhower D, Isenhower L, Ishihara M, Isobe T, Issah M, Isupov A, Ivanishchev D, Iwanaga Y, Jacak BV, Jezghani M, Jia J, Jiang X, Jin J, Jinnouchi O, John D, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kametani S, Kamihara N, Kamin J, Kanda S, Kaneta M, Kaneti S, Kang BH, Kang JH, Kang JS, Kanou H, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Key JA, Khachatryan V, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim C, Kim DH, Kim DJ, Kim E, Kim EJ, Kim GW, Kim M, Kim SH, Kim YJ, Kim YK, Kimelman B, Kinney E, Kiriluk K, Kiss Á, Kistenev E, Kitamura R, Kiyomichi A, Klatsky J, Klay J, Klein-Boesing C, Kleinjan D, Kline P, Koblesky T, Kochenda L, Kochetkov V, Komkov B, Konno M, Koster J, Kotchetkov D, Kotov D, Kozlov A, Král A, Kravitz A, Kubart J, Kunde GJ, Kurihara N, Kurita K, Kurosawa M, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Layton D, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee MK, Lee S, Lee SH, Lee SR, Lee T, Leitch MJ, Leite MAL, Lenzi B, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Litvinenko A, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Makek M, Malakhov A, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Mašek L, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Mikeš P, Miki K, Miller TE, Milov A, Mioduszewski S, Mishra DK, Mishra M, Mitchell JT, Mitrovski M, Miyachi Y, Miyasaka S, Mizuno S, Mohanty AK, Montuenga P, Moon HJ, Moon T, Morino Y, Morreale A, Morrison DP, Motschwiller S, Moukhanova TV, Mukhopadhyay D, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagata Y, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Nattrass C, Netrakanti PK, Newby J, Nguyen M, Nihashi M, Niida T, Nishimura S, Norman BE, Nouicer R, Novak T, Novitzky N, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Ohnishi H, Oka M, Okada K, Omiwade OO, Onuki Y, Orjuela Koop JD, Osborn JD, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pal D, Palounek APT, Pantuev V, Papavassiliou V, Park BH, Park IH, Park J, Park JS, Park S, Park SK, Park WJ, Pate SF, Patel L, Patel M, Pei H, Peng JC, Pereira H, Perepelitsa DV, Perera GDN, Peresedov V, Peressounko DY, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani RP, Proissl M, Purschke ML, Purwar AK, Qu H, Rak J, Rakotozafindrabe A, Ramson BJ, Ravinovich I, Read KF, Rembeczki S, Reuter M, Reygers K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Roach D, Roche G, Rolnick SD, Romana A, Rosati M, Rosen CA, Rosendahl SSE, Rosnet P, Rowan Z, Rubin JG, Rukoyatkin P, Ružička P, Rykov VL, Sahlmueller B, Saito N, Sakaguchi T, Sakai S, Sakashita K, Sakata H, Sako H, Samsonov V, Sano S, Sarsour M, Sato S, Sato T, Savastio M, Sawada S, Schaefer B, Schmoll BK, Sedgwick K, Seele J, Seidl R, Semenov AY, Semenov V, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shevel A, Shibata TA, Shigaki K, Shim HH, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Skutnik S, Slunečka M, Snowball M, Sodre T, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Suire C, Sukhanov A, Sumita T, Sun J, Sziklai J, Tabaru T, Takagi S, Takagui EM, Takahara A, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tarján P, Tennant E, Themann H, Thomas D, Thomas TL, Tieulent R, Timilsina A, Todoroki T, Togawa M, Toia A, Tojo J, Tomášek L, Tomášek M, Tomita Y, Torii H, Towell CL, Towell R, Towell RS, Tram VN, Tserruya I, Tsuchimoto Y, Utsunomiya K, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Vinogradov AA, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wagner M, Walker D, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White AS, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Xia B, Xie W, Xue L, Yalcin S, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Yasin Z, Ying J, Yokkaichi S, Yoo JH, Yoo JS, Yoon I, You Z, Young GR, Younus I, Yu H, Yushmanov IE, Zajc WA, Zaudtke O, Zelenski A, Zhang C, Zhou S, Zimamyi J, Zolin L, Zou L. Measurements of Elliptic and Triangular Flow in High-Multiplicity 3He+Au Collisions at √(s(NN))=200 GeV. PHYSICAL REVIEW LETTERS 2015; 115:142301. [PMID: 26551807 DOI: 10.1103/physrevlett.115.142301] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2015] [Indexed: 06/05/2023]
Abstract
We present the first measurement of elliptic (v(2)) and triangular (v(3)) flow in high-multiplicity (3)He+Au collisions at √(s(NN))=200 GeV. Two-particle correlations, where the particles have a large separation in pseudorapidity, are compared in (3)He+Au and in p+p collisions and indicate that collective effects dominate the second and third Fourier components for the correlations observed in the (3)He+Au system. The collective behavior is quantified in terms of elliptic v(2) and triangular v(3) anisotropy coefficients measured with respect to their corresponding event planes. The v(2) values are comparable to those previously measured in d+Au collisions at the same nucleon-nucleon center-of-mass energy. Comparisons with various theoretical predictions are made, including to models where the hot spots created by the impact of the three (3)He nucleons on the Au nucleus expand hydrodynamically to generate the triangular flow. The agreement of these models with data may indicate the formation of low-viscosity quark-gluon plasma even in these small collision systems.
Collapse
|
83
|
Kenna G, Haass-Koffler C, Swift R, Zywiak W, Brickley M, Edwards S, Leggio L. P86A PILOT DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL USING DOXAZOSIN FOR ALCOHOL DEPENDENCE. Alcohol Alcohol 2015. [DOI: 10.1093/alcalc/agv080.86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
84
|
Vicente C, Edwards S, Hillman K, Kaufmann S, Mitchell H, Bain L, Glubb D, Lee J, French J, Ferreira M. Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants. Am J Hum Genet 2015. [PMID: 26211970 DOI: 10.1016/j.ajhg.2015.06.010] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
The gene(s) whose expression is regulated by allergy risk variants is unknown for many loci identified through genome-wide association studies. Addressing this knowledge gap might point to new therapeutic targets for allergic disease. The aim of this study was to identify the target gene(s) and the functional variant(s) underlying the association between rs7009110 on chromosome 8q21 and allergies. Eight genes are located within 1 Mb of rs7009110. Multivariate association analysis of publicly available exon expression levels from lymphoblastoid cell lines (LCLs) identified a significant association between rs7009110 and the expression of a single gene, PAG1 (p = 0.0017), 732 kb away. Analysis of histone modifications and DNase I hypersensitive sites in LCLs identified four putative regulatory elements (PREs) in the region. Chromosome conformation capture confirmed that two PREs interacted with the PAG1 promoter, one in allele-specific fashion. To determine whether these PREs were functional, LCLs were transfected with PAG1 promoter-driven luciferase reporter constructs. PRE3 acted as a transcriptional enhancer for PAG1 exclusively when it carried the rs2370615:C allergy predisposing allele, a variant in complete linkage disequilibrium with rs7009110. As such, rs2370615, which overlaps RelA transcription factor (TF) binding in LCLs and was found to disrupt Foxo3a binding to PRE3, represents the putative functional variant in this locus. Our studies suggest that the risk-associated allele of rs2370615 predisposes to allergic disease by increasing PAG1 expression, which might promote B cell activation and have a pro-inflammatory effect. Inhibition of PAG1 expression or function might have therapeutic potential for allergic diseases.
Collapse
|
85
|
Murray T, Nettles M, Selmes N, Cathles LM, Burton JC, James TD, Edwards S, Martin I, O'Farrell T, Aspey R, Rutt I, Baugé T. Ice sheets. Reverse glacier motion during iceberg calving and the cause of glacial earthquakes. Science 2015; 349:305-8. [PMID: 26113640 DOI: 10.1126/science.aab0460] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Accepted: 06/12/2015] [Indexed: 11/02/2022]
Abstract
Nearly half of Greenland's mass loss occurs through iceberg calving, but the physical mechanisms operating during calving are poorly known and in situ observations are sparse. We show that calving at Greenland's Helheim Glacier causes a minutes-long reversal of the glacier's horizontal flow and a downward deflection of its terminus. The reverse motion results from the horizontal force caused by iceberg capsize and acceleration away from the glacier front. The downward motion results from a hydrodynamic pressure drop behind the capsizing berg, which also causes an upward force on the solid Earth. These forces are the source of glacial earthquakes, globally detectable seismic events whose proper interpretation will allow remote sensing of calving processes occurring at increasing numbers of outlet glaciers in Greenland and Antarctica.
Collapse
|
86
|
Westaway K, Frank O, Husband A, McClure A, Shute R, Edwards S, Curtis J, Rowett D. Medicines can affect thermoregulation and accentuate the risk of dehydration and heat-related illness during hot weather. J Clin Pharm Ther 2015; 40:363-7. [DOI: 10.1111/jcpt.12294] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2015] [Accepted: 05/07/2015] [Indexed: 11/28/2022]
|
87
|
Adare A, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Bataineh H, Al-Ta'ani H, Alexander J, Andrews KR, Angerami A, Aoki K, Apadula N, Appelt E, Aramaki Y, Armendariz R, Aschenauer EC, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Bannier B, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Belikov S, Belmont R, Ben-Benjamin J, Bennett R, Bhom JH, Blau DS, Bok JS, Boyle K, Brooks ML, Broxmeyer D, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Campbell S, Caringi A, Castera P, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Conesa Del Valle Z, Connors M, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Das K, Datta A, David G, Dayananda MK, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Donadelli M, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, D'Orazio L, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gal C, Garishvili I, Glenn A, Gong H, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gunji T, Guo L, Gustafsson HÅ, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Han R, Hanks J, Harper C, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hori Y, Hornback D, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Inaba M, Iordanova A, Isenhower D, Ishihara M, Issah M, Ivanischev D, Iwanaga Y, Jacak BV, Jia J, Jiang X, Jin J, John D, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kamin J, Kaneti S, Kang BH, Kang JH, Kang JS, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim DJ, Kim EJ, Kim YJ, Kim YK, Kinney E, Kiss Á, Kistenev E, Kleinjan D, Kline P, Kochenda L, Komkov B, Konno M, Koster J, Kotov D, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee SH, Lee SR, Leitch MJ, Leite MAL, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Miki K, Milov A, Mitchell JT, Miyachi Y, Mohanty AK, Moon HJ, Morino Y, Morreale A, Morrison DP, Motschwiller S, Moukhanova TV, Murakami T, Murata J, Nagamiya S, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Newby J, Nguyen M, Nihashi M, Nouicer R, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park BH, Park IH, Park SK, Park WJ, Pate SF, Patel L, Pei H, Peng JC, Pereira H, Peressounko DY, Petti R, Pinkenburg C, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ravinovich I, Read KF, Rembeczki S, Reygers K, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Samsonov V, Sano S, Sarsour M, Sato T, Savastio M, Sawada S, Sedgwick K, Seele J, Seidl R, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shim HH, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Sodre T, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stenlund E, Stoll SP, Sugitate T, Sukhanov A, Sun J, Sziklai J, Takagui EM, Takahara A, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tennant E, Themann H, Thomas D, Thomas TL, Togawa M, Toia A, Tomášek L, Tomášek M, Torii H, Towell RS, Tserruya I, Tsuchimoto Y, Utsunomiya K, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, Yoo JS, You Z, Young GR, Younus I, Yushmanov IE, Zajc WA, Zelenski A, Zhou S. Measurement of Long-Range Angular Correlation and Quadrupole Anisotropy of Pions and (Anti)Protons in Central d+Au Collisions at sqrt[s_{NN}]=200 GeV. PHYSICAL REVIEW LETTERS 2015; 114:192301. [PMID: 26024164 DOI: 10.1103/physrevlett.114.192301] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2014] [Indexed: 06/04/2023]
Abstract
We present azimuthal angular correlations between charged hadrons and energy deposited in calorimeter towers in central d+Au and minimum bias p+p collisions at sqrt[s_{NN}]=200 GeV. The charged hadron is measured at midrapidity |η|<0.35, and the energy is measured at large rapidity (-3.7<η<-3.1, Au-going direction). An enhanced near-side angular correlation across |Δη|>2.75 is observed in d+Au collisions. Using the event plane method applied to the Au-going energy distribution, we extract the anisotropy strength v_{2} for inclusive charged hadrons at midrapidity up to p_{T}=4.5 GeV/c. We also present the measurement of v_{2} for identified π^{±} and (anti)protons in central d+Au collisions, and observe a mass-ordering pattern similar to that seen in heavy-ion collisions. These results are compared with viscous hydrodynamic calculations and measurements from p+Pb at sqrt[s_{NN}]=5.02 TeV. The magnitude of the mass ordering in d+Au is found to be smaller than that in p+Pb collisions, which may indicate smaller radial flow in lower energy d+Au collisions.
Collapse
|
88
|
Sundararajan K, Gopaldas JA, Somehsa H, Edwards S, Shaw D, Sambrook P. Morbidity and mortality in patients admitted with submandibular space infections to the intensive care unit. Anaesth Intensive Care 2015; 43:420-422. [PMID: 25943620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
89
|
Ncomanzi D, Edwards S, Sundararajan K. Outcomes and clinical characteristics of critically ill patients requiring inferior vena cava filters in a tertiary referral centre. Anaesth Intensive Care 2015; 43:422-424. [PMID: 25943621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
90
|
Nisbet AP, Shaw P, Taube D, Edwards S, Fogelman I, Maisey M, Mashiter G. A simple noninvasive method for assessing renal osteodystrophy. CONTRIBUTIONS TO NEPHROLOGY 2015; 56:205-9. [PMID: 3111788 DOI: 10.1159/000413807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
91
|
Edwards S, Gange AC, Wiesel I. Spatiotemporal resource partitioning of water sources by African carnivores on Namibian commercial farmlands. J Zool (1987) 2015. [DOI: 10.1111/jzo.12248] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
92
|
Chia S, Gandhi S, Joy A, Edwards S, Gorr M, Hopkins S, Kondejewski J, Ayoub J, Califaretti N, Rayson D, Dent S. Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer. Curr Oncol 2015; 22:33-48. [PMID: 25684987 PMCID: PMC4324342 DOI: 10.3747/co.22.2393] [Citation(s) in RCA: 83] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
UNLABELLED The pi3k/Akt/mtor (phosphatidylinositol 3 kinase/ Akt/mammalian target of rapamycin) signalling pathway is an established driver of oncogenic activity in human malignancies. Therapeutic targeting of this pathway holds significant promise as a treatment strategy. Everolimus, an mtor inhibitor, is the first of this class of agents approved for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Everolimus has been associated with significant improvements in progression-free survival; however, it is also associated with increased toxicity related to its specific mechanism of action. METHODS A comprehensive review of the literature conducted using a focused medline search was combined with a search of current trials at http://ClinicalTrials.gov/. Summary tables of the toxicities of the various classes of pi3k/Akt/mtor inhibitors were created. A broad group of Canadian health care professionals was assembled to review the data and to produce expert opinion and summary recommendations for possible best practices in managing the adverse events associated with these pathway inhibitors. RESULTS Differing toxicities are associated with the various classes of pi3k/Akt/mtor pathway inhibitors. The most common unique adverse events observed in everolimus clinical trials in breast cancer include stomatitis (all grades: approximately 60%), noninfectious pneumonitis (15%), rash (40%), hyperglycemia (15%), and immunosuppression (40%). To minimize grades 3 and 4 toxicities and to attempt to attain optimal outcomes, effective management of those adverse events is critical. Management should be interdisciplinary and should use approaches that include education, early recognition, active intervention, and potentially prophylactic strategies. DISCUSSION Everolimus likely represents the first of many complex oral targeted therapies for the treatment of breast cancer. Using this agent as a template, it is essential to establish best practices involving and integrating multiple disciplines for the management of future pi3k/Akt/mtor signalling pathway inhibitors.
Collapse
|
93
|
Roberts N, Ward M, Patel I, Yorke J, Williams J, Walters R, McKevitt M, Edwards S. P114 What Skills, Experience And Training Are Need To Work In Integrated Respiratory Specialist Roles And How Can We Roll These Posts Out In The Uk? Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
94
|
Imathiu S, Edwards S, Ray R, Back M. Review article: Artificial inoculum and inoculation techniques commonly used in the investigation of Fusarium head blight in cereals. ACTA ACUST UNITED AC 2014. [DOI: 10.1556/aphyt.49.2014.2.1] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
95
|
Futaba K, Cagigas C, Rawstorne E, Ferguson H, Deakin A, Edwards S, Ismail T. Extralevator abdominoperineal resection--a video vignette. Colorectal Dis 2014; 16:1021-2. [PMID: 25116121 DOI: 10.1111/codi.12743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2014] [Accepted: 08/08/2014] [Indexed: 02/08/2023]
|
96
|
Roberts N, Ward M, Patel I, Yorke J, Williams J, Walters R, McKevitt M, Edwards S. P34 What Is Integrated Care And What Is The Value Of An Integrated Respiratory Specialist? Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
97
|
Edwards S, Fox R, Draycott T. Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study. BJOG 2014; 121:1754-5. [DOI: 10.1111/1471-0528.13123] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/14/2014] [Indexed: 11/26/2022]
|
98
|
Ishtiaq S, Edwards S, Sankaralingam A, Evans BAJ, Elford C, Frost ML, Fogelman I, Hampson G. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Cytokine 2014; 71:154-60. [PMID: 25461393 DOI: 10.1016/j.cyto.2014.10.025] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2014] [Revised: 08/29/2014] [Accepted: 10/28/2014] [Indexed: 12/28/2022]
Abstract
Bisphosphonates (BPs) have been shown to influence angiogenesis. This may contribute to BP-associated side-effects such as osteonecrosis of the jaw (ONJ) or atypical femoral fractures (AFF). The effect of BPs on the production of angiogenic factors by osteoblasts is unclear. The aims were to investigate the effect of (1) alendronate on circulating angiogenic factors; vascular endothelial growth factor (VEGF) and angiopoietin-1 (ANG-1) in vivo and (2) zoledronate and alendronate on the production of VEGF and ANG-1 by osteoblasts in vitro. We studied 18 post-menopausal women with T score⩽-2 randomized to calcium/vitamin D only (control arm, n=8) or calcium/vitamin D and alendronate 70mg weekly (treatment arm, n=10). Circulating concentrations of VEGF and ANG-1 were measured at baseline, 3, 6 and 12months. Two human osteoblastic cell lines (MG-63 and HCC1) and a murine osteocytic cell line (MLO-Y4) were treated with zoledronate or alendronate at concentrations of 10(-12)-10(-6)M. VEGF and ANG-1 were measured in the cell culture supernatant. We observed a trend towards a decline in VEGF and ANG-1 at 6 and 12months following treatment with alendronate (p=0.08). Production of VEGF and ANG-1 by the MG-63 and HCC1 cells decreased significantly by 34-39% (p<0.01) following treatment with zoledronate (10(-9)-10(-6)M). Treatment of the MG-63 cells with alendronate (10(-7) and 10(-6)) led to a smaller decrease (25-28%) in VEGF (p<0.05). Zoledronate (10(-10)-10(-)(6)M) suppressed the production of ANG-1 by MG-63 cells with a decrease of 43-49% (p<0.01). Co-treatment with calcitriol (10(-8)M) partially reversed this zoledronate-induced inhibition. BPs suppress osteoblastic production of angiogenic factors. This may explain, in part, the pathogenesis of the BP-associated side-effects.
Collapse
|
99
|
Edwards S, Fairbrother S, Scowcroft A, White L, Lipworth B. P248 Current Copd Disease Burden Associated With Maintenance Monotherapy In The Uk. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.376] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
100
|
Adare A, Afanasiev S, Aidala C, Ajitanand N, Akiba Y, Al-Bataineh H, Alexander J, Angerami A, Aoki K, Apadula N, Aphecetche L, Aramaki Y, Asai J, Atomssa E, Averbeck R, Awes T, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Baldisseri A, Barish K, Barnes P, Bassalleck B, Basye A, Bathe S, Batsouli S, Baublis V, Baumann C, Bazilevsky A, Belikov S, Belmont R, Bennett R, Berdnikov A, Berdnikov Y, Bhom J, Bickley A, Blau D, Boissevain J, Bok J, Borel H, Boyle K, Brooks M, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Camacho C, Campbell S, Caringi A, Chang B, Chang W, Charvet JL, Chen CH, Chernichenko S, Chi C, Chiu M, Choi I, Choi J, Choudhury R, Christiansen P, Chujo T, Chung P, Churyn A, Chvala O, Cianciolo V, Citron Z, Cole B, Conesa del Valle Z, Connors M, Constantin P, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Das K, Datta A, David G, Dayananda M, Denisov A, d’Enterria D, Deshpande A, Desmond E, Dharmawardane K, Dietzsch O, Dion A, Donadelli M, Drapier O, Drees A, Drees K, Dubey A, Durham J, Durum A, Dutta D, Dzhordzhadze V, D’Orazio L, Edwards S, Efremenko Y, Ellinghaus F, Engelmore T, Enokizono A, En’yo H, Esumi S, Eyser K, Fadem B, Feege N, Fields D, Finger M, Finger M, Fleuret F, Fokin S, Fraenkel Z, Frantz J, Franz A, Frawley A, Fujiwara K, Fukao Y, Fusayasu T, Garishvili I, Glenn A, Gong H, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene S, Grim G, Grosse Perdekamp M, Gunji T, Gustafsson HÅ, Hadj Henni A, Haggerty J, Hahn K, Hamagaki H, Hamblen J, Han R, Hanks J, Hartouni E, Haruna K, Haslum E, Hayano R, He X, Heffner M, Hemmick T, Hester T, Hill J, Hohlmann M, Holzmann W, Homma K, Hong B, Horaguchi T, Hornback D, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Imrek J, Inaba M, Isenhower D, Ishihara M, Isobe T, Issah M, Isupov A, Ivanischev D, Iwanaga Y, Jacak B, Jia J, Jiang X, Jin J, Johnson B, Jones T, Joo K, Jouan D, Jumper D, Kajihara F, Kametani S, Kamihara N, Kamin J, Kang J, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev A, Kempel T, Khanzadeev A, Kijima K, Kikuchi J, Kim A, Kim B, Kim D, Kim D, Kim E, Kim EJ, Kim S, Kim YJ, Kinney E, Kiriluk K, Kiss Á, Kistenev E, Klay J, Klein-Boesing C, Kleinjan D, Kochenda L, Komkov B, Konno M, Koster J, Kozlov A, Král A, Kravitz A, Kunde G, Kurita K, Kurosawa M, Kweon M, Kwon Y, Kyle G, Lacey R, Lai Y, Lajoie J, Layton D, Lebedev A, Lee D, Lee J, Lee K, Lee K, Lee T, Leitch M, Leite M, Lenzi B, Li X, Lichtenwalner P, Liebing P, Linden Levy L, Liška T, Litvinenko A, Liu H, Liu M, Love B, Lynch D, Maguire C, Makdisi Y, Malakhov A, Malik M, Manko V, Mannel E, Mao Y, Mašek L, Masui H, Matathias F, McCumber M, McGaughey P, McGlinchey D, Means N, Meredith B, Miake Y, Mibe T, Mignerey A, Mikeš P, Miki K, Milov A, Mishra M, Mitchell J, Mohanty A, Moon H, Morino Y, Morreale A, Morrison D, Moukhanova T, Mukhopadhyay D, Murakami T, Murata J, Nagamiya S, Nagle J, Naglis M, Nagy M, Nakagawa I, Nakamiya Y, Nakamura K, Nakamura T, Nakano K, Nam S, Newby J, Nguyen M, Nihashi M, Niida T, Nouicer R, Nyanin A, Oakley C, O’Brien E, Oda S, Ogilvie C, Oka M, Okada K, Onuki Y, Oskarsson A, Ouchida M, Ozawa K, Pak R, Palounek A, Pantuev V, Papavassiliou V, Park I, Park J, Park S, Park W, Pate S, Pei H, Peng JC, Pereira H, Peresedov V, Peressounko D, Petti R, Pinkenburg C, Pisani R, Proissl M, Purschke M, Purwar A, Qu H, Rak J, Rakotozafindrabe A, Ravinovich I, Read K, Rembeczki S, Reygers K, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick S, Rosati M, Rosen C, Rosendahl S, Rosnet P, Rukoyatkin P, Ružička P, Rykov V, Sahlmueller B, Saito N, Sakaguchi T, Sakai S, Sakashita K, Samsonov V, Sano S, Sato T, Sawada S, Sedgwick K, Seele J, Seidl R, Semenov A, Semenov V, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva C, Silvermyr D, Silvestre C, Sim K, Singh B, Singh C, Singh V, Slunečka M, Soldatov A, Soltz R, Sondheim W, Sorensen S, Sourikova I, Staley F, Stankus P, Stenlund E, Stepanov M, Ster A, Stoll S, Sugitate T, Suire C, Sukhanov A, Sziklai J, Takagui E, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tarján P, Themann H, Thomas D, Thomas T, Togawa M, Toia A, Tomášek L, Tomita Y, Torii H, Towell R, Tram VN, Tserruya I, Tsuchimoto Y, Vale C, Valle H, van Hecke H, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Vinogradov A, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wang X, Watanabe D, Watanabe K, Watanabe Y, Wei F, Wei R, Wessels J, White S, Winter D, Woody C, Wright R, Wysocki M, Xie W, Yamaguchi Y, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, You Z, Young G, Younus I, Yushmanov I, Zajc W, Zaudtke O, Zhang C, Zhou S, Zolin L. Measurement of transverse-single-spin asymmetries for midrapidity and forward-rapidity production of hadrons in polarizedp+pcollisions ats=200and 62.4 GeV. Int J Clin Exp Med 2014. [DOI: 10.1103/physrevd.90.012006] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|